1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Zealand Pharma A/S
  6. News
  7. Summary
    ZEAL   DK0060257814

ZEALAND PHARMA A/S

(ZEAL)
  Report
Delayed Nasdaq Copenhagen  -  10:59 2022-06-24 am EDT
98.35 DKK   +2.66%
06/21Iktos and Zealand Pharma A/S to Develop Artificial Intelligence Technology for Peptide Drug Design
CI
06/17European ADRs Move Lower in Friday Trading
MT
06/16European ADRs Fall Sharply in Thursday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Climb Sharply Higher in Monday Trading

05/23/2022 | 11:19am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC -6.90% 1.62 Delayed Quote.-56.80%
AUTOLUS THERAPEUTICS PLC 2.80% 2.57 Delayed Quote.-50.48%
AVADEL PHARMACEUTICALS PLC -4.94% 2.31 Delayed Quote.-71.41%
BARCLAYS PLC 3.40% 159.32 Delayed Quote.-14.80%
BP PLC 2.77% 386.05 Delayed Quote.16.81%
CARNIVAL CORPORATION 12.44% 10.85 Delayed Quote.-46.07%
ERYTECH PHARMA S.A. 0.00% 1.142 Real-time Quote.-46.13%
FORWARD PHARMA A/S 4.19% 4.48 Delayed Quote.-24.96%
LONDON BRENT OIL 1.28% 113.64 Delayed Quote.44.36%
OPERA LIMITED 0.89% 4.54 Delayed Quote.-35.69%
SEQUANS COMMUNICATIONS S.A. 5.67% 2.61 Delayed Quote.-44.94%
SHELL PLC 2.88% 2087.5 Delayed Quote.28.72%
TRIVAGO N.V. 3.25% 1.59 Delayed Quote.-27.06%
VODAFONE GROUP PLC 0.00% 126.5 Delayed Quote.12.68%
WTI 1.29% 108.055 Delayed Quote.38.53%
ZEALAND PHARMA A/S 2.66% 98.35 Delayed Quote.-32.22%
All news about ZEALAND PHARMA A/S
06/21Iktos and Zealand Pharma A/S to Develop Artificial Intelligence Technology for Peptide ..
CI
06/17European ADRs Move Lower in Friday Trading
MT
06/16European ADRs Fall Sharply in Thursday Trading
MT
06/15Transactions in Zealand Pharma A/S securities by persons discharging managerial respons..
GL
06/15Transactions in Zealand Pharma A/S securities by persons discharging managerial respons..
AQ
06/10ZEALAND PHARMA MAJOR SHAREHOLDER ANN : Credit Suisse Group AG, 2022
GL
06/10ZEALAND PHARMA MAJOR SHAREHOLDER ANN : Credit Suisse Group AG, 2022
AQ
06/09European ADRs Move Lower in Thursday Trading
MT
06/08European ADRs Move Lower in Wednesday Trading
MT
06/07Zealand Pharma's Potential Drug for Obesity Shows Acceptable Safety Profile in Phase 1 ..
MT
More news
Analyst Recommendations on ZEALAND PHARMA A/S
More recommendations
Financials
Sales 2022 263 M 37,3 M 37,3 M
Net income 2022 -1 103 M -156 M -156 M
Net cash 2022 683 M 96,9 M 96,9 M
P/E ratio 2022 -3,59x
Yield 2022 -
Capitalization 4 535 M 643 M 643 M
EV / Sales 2022 14,6x
EV / Sales 2023 7,69x
Nbr of Employees 345
Free-Float 99,0%
Chart ZEALAND PHARMA A/S
Duration : Period :
Zealand Pharma A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZEALAND PHARMA A/S
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 98,35 DKK
Average target price 218,80 DKK
Spread / Average Target 122%
EPS Revisions
Managers and Directors
Adam Sinding Steensberg President & Chief Executive Officer
Matthew D. Dallas Chief Financial Officer & Senior Vice President
Alf Gunnar Martin Nicklasson Chairman
Ivan M. Møller Executive VP-Technical Development & Operations
Danilo Verge Head-Global Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
ZEALAND PHARMA A/S-32.22%643
GILEAD SCIENCES, INC.-13.12%79 122
VERTEX PHARMACEUTICALS33.22%74 821
REGENERON PHARMACEUTICALS, INC.-3.01%65 993
WUXI APPTEC CO., LTD.-13.42%44 742
BIONTECH SE-48.01%32 574